Key facts
- It has raised $2.8M; the latest was Seed Round ($2.2M) in May 2024.
- Notable investors include Noshaq, Respond Accelerator, Ashoka (Arlington), CIRI Ventures, Circular Innovation Fund — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Novobiom
- ·The full record, as it builds
Funding rounds
No funding rounds for Novobiom are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Novobiom
Provider of waste management services and consultation intended to treat contaminated soil biologically. The company's mycoremediation technology uses mushrooms to deliver competitive and tailored remediation addressing problematic soil pollution and also provides sustainability awareness and innovation guidance through biomimetic lenses, enabling industries to achieve their strategic sustainability goals.
- Sector
- Business Products and Services (B2B)
- HQ
- Ottignies-Louvain-la-Neuve, Belgium
- Founded
- 2017
- Employees
- 20
- Website
- novobiom.com/
- Ownership
- Privately Held (backing)
Novobiom doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Novobiom shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Novobiom in its N-PORT filings yet. We sweep new filings monthly.